KECIA KEADY: Open Payments
NPI 1356930481 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 23 payments from 9 companies in 2025. Trend: 2023 $198 · 2024 $120 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $251 |
| Abbott Laboratories | 1 | $74 |
| SCPHARMACEUTICALS INC. | 3 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $50 |
| Boston Scientific Corporation | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| HEARTFLOW, INC. | 1 | $28 |
| Novo Nordisk Inc | 1 | $22 |
Products named: COREVALVE EVOLUT R, AVEIR, FUROSCIX, LifeVest, AURORA EV-ICD MRI SURESCAN, myLUX Patient Kit with mobile device, ELIQUIS, LINQ II.
Industry payments across IA — which companies pay providers there.
